2019
DOI: 10.1002/slct.201900799
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Docking Study of Pyrimidine Derivatives Scaffold for Anti‐Hypertension Application

Abstract: The present work introduces four new macromolecules pyrrolo[2,3‐d]pyrimidine scaffolds substituted with various benzene‐sulfonamide moieties; those were picked up via cyclization of 2‐amino‐3‐cyanopyrroles with phenyl isothiocyanate. The newly prepared pyrrolopyrimidine derivatives have been elucidated by spectroscopic techniques (FT‐IR, 1HNMR, 13CNMR and MS) and elemental analyses. The antihypertensive activity of the synthesized pyrrolopyrimidine derivatives based on sulfonamide moiety was evaluated. All pyr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 21 publications
(12 reference statements)
0
11
0
Order By: Relevance
“…Furthermore, from the previous literature, the SO 2 bridge in the sulfonamide moiety played a vital role in α1 A receptor blocking activity. [27] Finally, the synthesized analogues have a mutual framework in their structures; the noticed structural activity relationship is principally owing to the dissimilarity of other functionalities on this scaffold. While the difference in the structures on the chief scaffold at C3 is liable for dissimilarity in effectiveness potential while all structures are captivating portion in the action.…”
Section: Structural Activity Relationship (Sar)mentioning
confidence: 99%
“…Furthermore, from the previous literature, the SO 2 bridge in the sulfonamide moiety played a vital role in α1 A receptor blocking activity. [27] Finally, the synthesized analogues have a mutual framework in their structures; the noticed structural activity relationship is principally owing to the dissimilarity of other functionalities on this scaffold. While the difference in the structures on the chief scaffold at C3 is liable for dissimilarity in effectiveness potential while all structures are captivating portion in the action.…”
Section: Structural Activity Relationship (Sar)mentioning
confidence: 99%
“…Pyrimidines and DHPMs, the important lead compounds for treatment of hypertension [32] , have been developed as for SQ 32926, SQ 32,547 and some pyrimidines analogues ( Fig. 2 & Fig.…”
Section: Resultsmentioning
confidence: 99%
“…9 | ANTIHYPERTENSIVE ACTIVITY Katouah and Gaffer synthesized four pyrrolo [2,pyrimidine analogues (Scheme 30) possessing benzene sulfonamide component. 61d exhibited a potent activity by effectively decreasing the mean systolic blood pressure (SBP) of hypertensive rats using prazosin as the reference standard (Katouah & Gaffer, 2019).…”
Section: Anticonvulsant Activitymentioning
confidence: 99%